Patients who are unable to take their medication on the prescribed schedule (noncompliers) are a major cost to insurers. Those who take less than 80% of the prescribed doses (about 75% of patients) have more frequent hospitalizations and ER visits, and are likely to need more expensive medical care sooner.If your organization is paying for a patient's medications, you owe it to both your patients and your management to minimize overall costs by assuring that each patient derives the benefit of the prescribed medication.
The ZoltanCAP® has been shown to significantly improve clinical outcomes. See
Impact of an Electronic Medication Compliance Aid on Long-Term Blood Pressure Control J Clin Pharmacol. 1992;32:277-283
For more information please contact the patent holder:
Bart J. Zoltan
152 DeWolf Road
Old Tappan, NJ 07675